ON Semiconductor vs Tilray Brands Inc — how do they compare? ON Semiconductor trades at $81.04 (market cap $30.92B), while Tilray Brands Inc trades at $3.6 (market cap $530.54M). The key difference: ON Semiconductor is far larger — about 58.3× Tilray Brands Inc's market cap, and ON Semiconductor is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ON Semiconductor for 5 Days and Tilray Brands Inc for 31 Days on average.
| ON | TLRY | |
|---|---|---|
Market Cap | $30.92B | $530.54M |
Volume | 11,639,037 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $133.93 | $21.00 |
52-Week Low | $44.90 | $3.57 |
Typical Hold Time | 5 Days | 31 Days |
Enterprise Value | $31.53B | $684.46M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Onsemi develops power and sensing semiconductors for automotive, industrial, and energy applications. Its products support functions such as electric vehicle systems, energy conversion, automation, and intelligent sensing.
Read more on ON →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →